SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |
HARBOR CAPITAL ADVISORS, INC. | 34,773 | $715,628 | 0.15% |
Values First Advisors, Inc. | 10,626 | $218,693 | 0.14% |
XTX Topco Ltd | 38,093 | $783,954 | 0.13% |
Hennion & Walsh Asset Management, Inc. | 85,495 | $1,759,487 | 0.11% |
SEVEN EIGHT CAPITAL, LP | 42,632 | $877,367 | 0.10% |
AdvisorShares Investments LLC | 16,415 | $337,821 | 0.09% |
Cavalier Investments, LLC | 10,028 | $206,376 | 0.08% |
PROFUND ADVISORS LLC | 68,755 | $1,414,978 | 0.08% |
Alyeska Investment Group, L.P. | 528,821 | $10,883,136 | 0.07% |
Jump Financial, LLC | 88,301 | $1,817,235 | 0.07% |
External links
This page lists SAGE THERAPEUTICS INC's shareholders in Q3 2023. To view SAGE THERAPEUTICS INC's shareholder history, click here.